Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $370.8000 (1.48%) ($360.3800 - $375.3750) on Thu. Mar. 24, 2016. | |
| | Trend Analysis and Forecast | | | | Average Daily Percentage Swing | 2.64% (three month average) | | RSI | 30 | | Latest Price | $370.8000(1.48%) | | Stocks Behave Similarly | Similar Stock List | | Daily Trend | REGN advances 0.3% a day on average for past five trading days. | | Weekly Trend | REGN declines -2.7% a week on average for past two weeks. | | Market Behavior | Normal for large cap. Normal for small cap. | | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability)
IBB(63%) XLV(51%) XBI(48%) QQQ(41%) IVW(40%) | | Factors Impacting REGN price | REGN will decline at least -1.32% in a week (0% probabilities).
VIXM(-12%) UUP(-8%) TLT(-8%) IPO(-5%) SHY(-3%) | | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | | | | Relative Volatility | (options are extremely cheap) | | | | | Market Trend Strength | -1.32% (StdDev 2.64%) | | Hourly BBV | 0 () | | Intraday Trend | 2% | | | | | |
|
| Resistance Level | $382.15 | | 5 Day Moving Average | $370.01(0.21%) | | 10 Day Moving Average | $370.1(0.19%) | | 20 Day Moving Average | $382.15(-2.97%) | | To recent high | -32.6% | | To recent low | 1.7% | | Market Cap | $39.315b | | | | | | |
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |